Dr Garry Dolton - Publications

8. Bulek, A.M, D.K. Cole, A. Skowera, G. Dolton, S. Gras, F. Madura, A. Fuller, J.J. Miles, E. Gostick, D.A. Price, J.W. Drijfhout, R.R. Knight, N. Lissin, P.E. Molloy, L. Wooldridge, B.K. Jakobsen, J. Rossjohn, M. Peakman, P.J. Rizkallah and A.K. Sewell (2012) Structural basis of human b-cell killing by preproinsulin-specific CD8+ T-cells in type 1 diabetes. Nature Immunology 13; 283-89.

7. Nunes, C. T., Smith, K. L., Dolton, G., Pepper, C., Feagon, C., Mason, M. D., and Man, S. (2011). A novel tumor antigen derived from enhanced degradation of Bax protein in human cancers. Cancer Research. Aug 15:71 (16) 5435-44.

6. Wooldridge, L., J. Ekeruche-Makinde, H.A. van den Berg, A. Skowera, J.J. Miles, M.P. Tan, G. Dolton, M. Clement, S. Llewellyn-Lacey, D.A. Price, M. Peakman and A.K. Sewell (2011) A single autoimmune T-cell receptor recognises over a million different peptides. Journal of Biological Chemistry 287; 1168-77.

5. Clement, M., K. Ladell, J. Ekeruche-Makinde, J.J. Miles, E.S.J. Edwards, G. Dolton, T. Williams, A.J.A. Schauenburg, D.K. Cole, S.N. Lauder, A.M. Gallimore, A.J. Godkin, S.R. Burrows, D.A. Price, L. Wooldridge¶ and A.K. Sewell¶ (2011) Anti-CD8 antibodies can trigger CD8+ T cell effector function in the absence of TCR engagement and improve peptide-MHCI tetramer staining. Journal of Immunology, 187, 654-63 (¶Equal contribution).

4. Miles, J.J., A.M. Bulek, D.K. Cole, E. Gostick, A.J.A. Schauenburg, G. Dolton, V. Venturi, M.P. Davenport, M.P. Tan, S.R. Burrows, L. Wooldridge, D.A. Price, P.J. Rizkallah and A.K. Sewell (2010) Genetic and Structural Basis for Selection of a Ubiquitous T Cell Receptor Deployed in Epstein-Barr Virus Infection. PLoS Pathogens Nov 18:6 (11).

3. Cuff, S., Dolton, G., Matthews R. J., and Gallimore, A. Antigen specificity determines the pro- or anti-tumoural nature of CD8+ T cells (2010). Journal of Immunology. 184:2 607-614.

2. Sathish, J. G., Dolton, G., Leroy, F. G., and Matthews, R. J. (2007). Loss of Src homology region 2 domain-containing protein tyrosine phosphatase-1 increases CD8+ T cell-APC conjugate formation and is associated with enhanced in vivo CTL function. Journal of Immunology. 1 78:1, 330-337.

1. Dolton, G. M., Sathish, J. G., and Matthews, R. J. (2006). Protein tyrosine phosphatases as negative regulators of the immune response. Biochemical Society Transactions. 34:6, 1041-1045.